Background: A key metabolic alteration in tumour cells is increased dependency on glycolysis, resulting in the production of lactate which is transported out of cells by MCTs. Inhibition of MCT-1 can constrain cancer cell growth in preclinical models. We report results on the phase I study of AZD3965, a FIC inhibitor of MCT-1.
http://ift.tt/2oQwJu9
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου